Eligibility of patients with type 2 diabetes for sodium‐glucose co‐transporter‐2 inhibitor cardiovascular outcomes trials: An assessment using the Diabetes Collaborative Registry

Generalizability of findings from cardiovascular outcomes trials (CVOTs) to patients with type 2 diabetes (T2D) in clinical practice is unknown. We assessed the proportions of patients in the Diabetes Collaborative Registry who would have met enrolment criteria for pivotal CVOTs of sodium‐glucose co...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Diabetes Obes Metab
Hlavní autoři: Wittbrodt, Eric, Chamberlain, David, Arnold, Suzanne V., Tang, Fengming, Kosiborod, Mikhail
Médium: Artigo
Jazyk:Inglês
Vydáno: Blackwell Publishing Ltd 2019
Témata:
Brief Reports
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6767768/
https://ncbi.nlm.nih.gov/pubmed/30968543
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13738
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky